Home
About Us
R&D
Jobs
News
Contact Us
Slide One
Protinhi
News
Slide One
Protinhi
News
€1.4M granted for pan-corona antiviral preclinical development_2
juli 5, 2023
Prev
Previous
IMM and consortium partners Protinhi Therapeutics and Artemis launched the preclinical development of pan-corona antiviral against COVID-19 and other corona viral threats
